Amol Ratnakar Suryawanshi

Dr. Amol Ratnakar Suryawanshi

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSriparna Mukherjee
Sriparna Mukherjee
NSNabonita Sengupta
Nabonita Sengupta
ACAnkur Chaudhuri
Ankur Chaudhuri
IAIrshad Akbar
Irshad Akbar
NSNoopur Singh
Noopur Singh
ABAnirban Basu
Anirban Basu
Japanese Encephalitis Virus (JEV), a globally important pathogen, belongs to the family Flaviviridae, is transmitted between vertebrate hosts by mosquitoes, principally by Culex tritaeniorhynchus. The E-glycoprotein of the virus mediates its attachment to the host cell receptors. In this study, we cloned and purified JEV E-glycoprotein in pET28a vector using E. coli BL21 (DE3) cells. A pull down assay was performed using plasma membrane fraction of BALB/c mouse brain and E-glycoprotein as a bait protein. 2-Dimensional Gel Electrophoresis based separation of the interacting proteins was analyzed by mass spectrometry. Among all the identified partners of E-glycoprotein, PLVAP (Plasmalemma vesicle associated protein) and GKN3 (Gastrokine3) showed significant up-regulation in both JEV infected mouse brain and neuro2a cells. In-silico studies also predicted significant interaction of these receptors with E-glycoprotein. Additionally, overexperssion and silencing of these receptors resulted in increase and reduction in viral load respectively, suggesting them as two critical cellular receptors governing JEV entry and propagation in neurons. In support, we observed significant expression of PLVAP but not GKN3 in post-mortem autopsied human brain tissue. Our results establish two novel receptor proteins in neurons in case of JEV infection, thus providing potential targets for antiviral research.

20 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Abhishek KumarAbhishek Kumar
Abhishek Kumar
PMPrabhudutta Mamidi
Prabhudutta Mamidi
IDIndrani Das
Indrani Das
TNTapas K. Nayak
Tapas K. Nayak
SKSameer Kumar
Sameer Kumar
ASAmol Ratnakar Suryawanshi
Amol Ratnakar Suryawanshi
The recent re-emergence of Chikungunya virus (CHIKV) in India after 32 years and its worldwide epidemics with unprecedented magnitude raised a great public health concern. In this study, a biological comparison was carried out between a novel 2006 Indian CHIKV outbreak strain, DRDE-06 and the prototype strain S-27 in mammalian cells in order to understand their differential infection pattern. Results showed that S-27 produced maximum number of progenies (2.43E+06 PFU/ml) at 20 to 24 hours post infection whereas DRDE-06 produced more than double number of progenies around 8 hours post infection in mammalian cells. Moreover, the observation of cytopathic effect, detection of viral proteins and viral proliferation assay confirmed the remarkably faster and significantly higher replication efficiency of DRDE-06. Moreover, our mutational analysis of whole genome of DRDE-06 revealed the presence of nineteen mutations as compared to S-27, whereas the analysis of 273 global isolates showed the consistent presence of fifteen out of nineteen mutations in almost all outbreak isolates. Further analysis revealed that ∼46% of recent outbreak strains including DRDE-06 do not contain the E1-A226V mutation which was earlier shown to be associated with the adaptation of CHIKV in a new vector species, Aedes albopictus. A novel 2006 Indian CHIKV outbreak strain, DRDE-06 exhibits different pattern of infection as compared to prototype strain, S-27. This might be associated to some specific mutations observed in genome wide mutational analysis in DRDE-06 which emphasizes the need of future experimental investigation.

9 June 2021 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
VSVoddu Suresh
Voddu Suresh
VMVarshasnata Mohanty
Varshasnata Mohanty
KAKiran Avula
Kiran Avula
AGArup Ghosh
Arup Ghosh
BSBharati Singh
Bharati Singh
SSShantibhusan Senapati
Shantibhusan Senapati
Syrian golden hamsters ( Mesocricetus auratus ) infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) manifests lung pathology. In this study, efforts were made to check the infectivity of a local SARS‐CoV‐2 isolate in a self‐limiting and non‐lethal hamster model and evaluate the differential expression of lung proteins during acute infection and convalescence. The findings of this study confirm the infectivity of this isolate in vivo. Analysis of clinical parameters and tissue samples show the pathophysiological manifestation of SARS‐CoV‐2 infection similar to that reported earlier in COVID‐19 patients and hamsters infected with other isolates. However, diffuse alveolar damage (DAD), a common histopathological feature of human COVID‐19 was only occasionally noticed. The lung‐associated pathological changes were very prominent on the 4th day post‐infection (dpi), mostly resolved by 14 dpi. Here, we carried out the quantitative proteomic analysis of the lung tissues from SARS‐CoV‐2‐infected hamsters on day 4 and day 14 post‐infection. This resulted in the identification of 1585 proteins of which 68 proteins were significantly altered between both the infected groups. Pathway analysis revealed complement and coagulation cascade, platelet activation, ferroptosis, and focal adhesion as the top enriched pathways. In addition, we also identified altered expression of two pulmonary surfactant‐associated proteins (Sftpd and Sftpb), known for their protective role in lung function. Together, these findings will aid in understanding the mechanism(s) involved in SARS‐CoV‐2 pathogenesis and progression of the disease.

23 July 2015 in F1000Research
Verified
Journal Article
Open access
PDF file
NSNabonita Sengupta
Nabonita Sengupta
SMSriparna Mukherjee
Sriparna Mukherjee
PTPiyush Tripathi
Piyush Tripathi
RKRashmi Kumar
Rashmi Kumar
ASAmol Ratnakar Suryawanshi
Amol Ratnakar Suryawanshi
ABAnirban Basu
Anirban Basu
Japanese encephalitis (JE) is the leading cause of viral encephalitis in Asia. Acute encephalitis syndrome (AES) is a group of central nervous system (CNS) disorders caused by a wide range of viruses, bacteria, fungi, chemicals and toxins. It is important to distinguish between various forms of infectious encephalitis with similar clinical manifestations in order to ensure specific and accurate diagnosis and development of subsequent therapeutic strategies. Cerebrospinal fluid (CSF) is in direct contact with the CNS and hence it is considered to be an excellent source for identifying biomarkers for various neurological disorders. With the recent advancement in proteomic methodologies, the field of biomarker research has received a remarkable boost. The present study identifies potential biomarkers for JE using a proteomics based approach. The CSF proteomes from ten patients each with JE and Non-JE acute encephalitis were analyzed by 2D gel electrophoresis followed by mass spectrometry. Vitamin D-binding protein (DBP), fibrinogen gamma chain, fibrinogen beta chain, complement C4-B, complement C3 and cytoplasmic actin were found to be significantly elevated in case of JE indicating severe disruption of the blood brain barrier and DBP can be suggested to be an important diagnostic marker.

1 February 2022 in Journal of Proteomics
Verified
Journal Article
Closed access
SBSuchismita Behera
Suchismita Behera
RRR. Rajendra Reddy
R. Rajendra Reddy
KTKhushman Taunk
Khushman Taunk
SRSrikanth Rapole
Srikanth Rapole
RPRajesh Raghunath Pharande
Rajesh Raghunath Pharande
ASAmol Ratnakar Suryawanshi
Amol Ratnakar Suryawanshi

2 November 2020 in Journal of Proteins and Proteomics
Verified
Journal Article
Closed access
PDF file
SBSuchismita Behera
Suchismita Behera
RPRajesh Raghunath Pharande
Rajesh Raghunath Pharande
RRR. Rajendra Reddy
R. Rajendra Reddy
SMSharmila B. Majee
Sharmila B. Majee
SMSandeepan Mukherjee
Sandeepan Mukherjee
ASAmol Ratnakar Suryawanshi
Amol Ratnakar Suryawanshi